gemfibrozil has been researched along with pyrimidinones in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gandhi, TR; Goyal, RK; Jain, KS; Rathod, IS; Shishoo, CJ | 1 |
Alfaro, RM; Busse, KH; Chairez, C; Formentini, E; Hadigan, C; Kovacs, JA; Penzak, SR | 1 |
Arya, N; Dwivedi, J; Jagdale, AY; Jain, KS; Munde, MK | 1 |
3 other study(ies) available for gemfibrozil and pyrimidinones
Article | Year |
---|---|
Mechanism of the antihyperlipaemic activity and pharmacokinetics of 2-chloromethyl-5,6,7,8-tetrahydrobenzo(b)thieno[2,3-d]pyrimidin-4(3H)-o ne.
Topics: Administration, Oral; Animals; Biological Availability; Cholesterol, Dietary; Chromatography, High Pressure Liquid; Dogs; Gemfibrozil; Hypolipidemic Agents; Injections, Intravenous; Intestinal Absorption; Pyrimidinones; Rabbits; Rats | 1997 |
Gemfibrozil concentrations are significantly decreased in the presence of lopinavir-ritonavir.
Topics: Adult; Anti-HIV Agents; Drug Antagonism; Female; Gemfibrozil; Healthy Volunteers; Humans; Hypolipidemic Agents; Lopinavir; Male; Middle Aged; Plasma; Pyrimidinones; Ritonavir | 2009 |
Design, synthesis, and antihyperlipidemic evaluation of novel 2-[1-(substitutedphenyl)-4-oxo-azetidin-2-yl]-5,6-disubstitutedthieno[2,3-d]pyrimidin-4(3H)-ones.
Topics: Animals; Azetidines; Biomarkers; Cholesterol; Disease Models, Animal; Drug Design; Gemfibrozil; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Intestinal Mucosa; Intestines; Molecular Structure; Polyethylene Glycols; Pyrimidinones; Rats; Rats, Wistar; Structure-Activity Relationship; Triglycerides | 2013 |